CAMEREN HACKLEY: Open Payments
NPI 1285185835 · MADISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 46 payments from 18 companies in 2025. Trend: 2023 $1,019 · 2024 $1,367 · 2025 $1,046
Food & beverage: $1,046
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $178 |
| Novo Nordisk Inc | 6 | $112 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Lilly USA, LLC | 3 | $80 |
| Esperion Therapeutics, Inc. | 4 | $76 |
| ABBVIE INC. | 3 | $69 |
| Astellas Pharma US Inc | 2 | $53 |
| Exact Sciences Corporation | 2 | $51 |
| Amgen Inc. | 2 | $37 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, CAPLYTA, NEXLETOL, VRAYLAR, Veozah, Cologuard Collection Kit, MOUNJARO.
Industry payments across TN — which companies pay providers there.
